导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 14.49% | 59/72 |
| 近一周 | -3.02% | 45/76 |
| 近一月 | 1.67% | 25/75 |
| 近一季 | 0.37% | 30/74 |
| 近半年 | 14.75% | 44/74 |
| 近一年 | 13.94% | 58/72 |
| 近两年 | 51.91% | 29/68 |
| 近三年 | 107.27% | 5/40 |
| 成立以来 | 464.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-10.76% 62/74 |
16.31% 23/74 |
10.94% 52/74 |
- - |
| 2024 | 32.68% 3/75 |
13.61% 3/67 |
7.20% 21/72 |
0.33% 58/74 |
8.58% 9/75 |
| 2023 | 38.84% 5/72 |
10.12% 7/57 |
18.21% 3/64 |
-3.79% 32/68 |
10.85% 18/72 |
| 2022 | -20.82% 24/46 |
-8.19% 16/43 |
-15.33% 36/45 |
1.86% 3/45 |
- 31/46 |
| 2021 | 22.45% 5/43 |
2.14% 132/312 |
7.83% 97/328 |
1.28% 37/358 |
9.77% 4/43 |
| 2020 | 26.93% 19/41 |
-12.32% 152/280 |
25.58% 76/295 |
8.56% 61/299 |
6.19% 190/305 |
| 2019 | 29.76% 6/35 |
10.91% 106/258 |
6.34% 12/268 |
2.93% 72/253 |
6.88% 120/266 |
| 2018 | 1.39% 2/31 |
- - |
- - |
- - |
-18.27% 203/241 |
| 2017 | 15.91% 27/30 |
- - |
- - |
- - |
- - |
| 2016 | 10.88% 4/31 |
- - |
- - |
- - |
- - |
| 2015 | 6.98% 4/30 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)A | 1.7664 | 36.41% |
| 嘉实全球产业升级股票发起式(QDII)A | 2.4908 | 10.73% |
| 景顺长城全球半导体芯片股票A(QDII-LOF)(美元现汇) | 0.2729 | 9.97% |
| 嘉实全球产业升级股票发起式(QDII)C | 2.4489 | 7.89% |
| 景顺长城全球半导体芯片股票A(QDII-LOF)(人民币) | 1.9263 | 6.91% |
| 景顺长城全球半导体芯片股票C(QDII-LOF)(人民币) | 1.9043 | 5.10% |
| 博时大中华亚太精选美元现汇 | 0.1503 | 4.67% |
| 易方达亚洲精选股票 | 1.3960 | 4.33% |
| 博时大中华亚太精选 | 1.0610 | 3.92% |
| 浦银安盛全球智能科技(QDII)C | 2.4366 | 3.82% |
| 嘉实美国成长股票人民币 VS. 华夏全球股票(QDII)(人民币)(000041) |